MANUFACTURING GAVI outlines priorities to support expanding sustainable vaccine manufacturing in Africa

which is supported by Gavi, with only about ten countries being self-sufficient in terms of vaccine procurement.

Although Africa consumes vaccines worth more than US$1 billion each year, Gavi, UNICEF, and donors bear a large portion of the cost. Gavi currently selects vaccine suppliers based on price and does not systematically permit the accommodation of higher prices in the name of geographical diversity and supply security.

SWITZERLAND — Gavi, the Vaccine Alliance has unveiled a plan outlining key priority areas to achieve the African Union (AU) vision of sustainably expanding vaccine manufacturing capacity across Africa by 2040. The plan is a response to the AU call to action for Gavi and other stakeholders to concretely support supply security on the continent. The plan has been developed in consultation with the AU and Africa Centres for Disease Control and Prevention (Africa CDC), as well as a wide range of supporting stakeholders.

The 10-point plan allocates responsibilities to other key players – G7 Development Ministers, African countries, international partners including development financial institutions, and the private sector – to support sustainable African manufacturing capacity. However, Gavi will drive and coordinate the plan, given its enormous clout as the world’s biggest buyer of vaccines. Most African countries receive vaccines from UNICEF,

Cleveland Clinic Abu Dhabi and UAEU ally on research and education

Emirates University (UAEU) focused on two key areas, research and education.

Cleveland Clinic Abu Dhabi and the College of Medicine and Health Sciences – UAEU have agreed to collaborate on research projects, co-mentoring, and placement of students at Cleveland Clinic Abu Dhabi, along with the creation of research and development partnerships.

together to produce Emirati doctors who are educated to the highest international standards while partnering on the development of jointly led healthcare events.

UAE – Cleveland Clinic Abu Dhabi, an integral part of Mubadala Health, has signed a collaboration agreement with the College of Medicine and Health Sciences (CMHS) of the United Arab

The two parties will also collaborate on educational projects at the undergraduate, graduate, and postdoctoral levels offered at the College of Medicine and Health Sciences, the first and highest-ranked medical school in the UAE. Moreover, Cleveland Clinic Abu Dhabi and CMHS will work closely

Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population. Commenting on the latest partnership, Dr. Sawsan Abdel-Razig, Interim Chief Academic Officer at Cleveland Clinic Abu Dhabi said: “Innovation, research, and education are key areas that Cleveland Clinic Abu Dhabi focuses on.”